Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

NCT01979536 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

NIH

Sponsor class

Conditions

Anaplastic Large Cell Lymphoma, ALK-Positive
Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma
Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma
Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma

Interventions

DRUG: Brentuximab Vedotin
DRUG: Crizotinib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Methotrexate

Sponsor

National Cancer Institute (NCI)